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Abstract
Aberrant Wnt signaling has been implicated in a wide variety of cancers and many components of the Wnt signaling
network have now been identified. Much less is known, however, about how these proteins are coordinately regulated.
Here, a broad, quantitative, and dynamic study of Wnt3a-mediated stimulation of HEK 293 cells revealed two phases of
transcriptional regulation: an early phase in which signaling antagonists were downregulated, providing positive feedback,
and a later phase in which many of these same antagonists were upregulated, attenuating signaling. The dynamic
expression profiles of several response genes, including MYC and CTBP1, correlated significantly with proliferation and
migration (P,0.05). Additionally, their levels tracked with the tumorigenicity of colon cancer cell lines and they were
significantly overexpressed in colorectal adenocarcinomas (P,0.05). Our data highlight CtBP1 as a transcription factor that
contributes to positive feedback during the early phases of Wnt signaling and serves as a novel marker for colorectal cancer
progression.
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Introduction
Wnt proteins constitute a family of highly conserved growth
factors [1] that mediate a wide range of biological processes,
including proliferation, migration, and differentiation. They also
control embryonic patterning and cell-fate decisions during early
development [2,3]. Aberrant activation of Wnt signaling has been
implicated in a variety of human developmental disorders [4] and
in malignancies of the colon, skin, brain, plasma, and prostate [5].
Most notably, activating mutations in components of the canonical
Wnt signaling pathway are observed in .90% of colorectal
cancers [6], and colorectal cancer is currently the second leading
cause of cancer-related deaths in the United States [7].
The canonical Wnt signaling pathway is activated when a Wnt
ligand binds to the transmembrane receptors frizzled (Fzd) and
low-density lipoprotein receptor-related protein (LRP) [8,9].
Ligand binding induces formation of a multiprotein complex that
includes Dishevelled-1 (Dvl), Fzd, and Axin. Recruitment of Axin
to this complex destabilizes the b-catenin degradation complex,
allowing b-catenin to accumulate in the cytoplasm and translocate
to the nucleus. Nuclear b-catenin activates transcription factors of
the T-cell factor/lymphoid enhancing factor (TCF/LEF) family by
displacing Groucho proteins and recruiting an array of co-
activator proteins such as BCL9/PYG and CBP [8,9]. This
induces expression of MYC (c-Myc), JUN (c-Jun), CCND1 (Cyclin
D1), and a variety of other response genes involved in growth,
differentiation, cell cycle progression, migration, and survival [10].
To date, numerous components of the Wnt network, from the
plasma membrane to the cell nucleus, have been identified [8]. In
addition to the canonical pathway described above, other signaling
pathways are also activated by Wnt ligands [4] and a more holistic
understanding of the overall topology of the network is beginning
to emerge. To date, however, a system-wide and quantitative
analysis of the dynamics of Wnt signaling has not been reported
and it remains unclear how positive and negative regulators of the
network are coordinately regulated.
To investigate how Wnt signaling proteins interrelate to control
normal cellular functions such as proliferation and migration, we
used serum-starved human embryonic kidney (HEK) 293 cells to
follow the transcript levels of virtually every protein that has been
implicated in Wnt signaling over a 24-h time course of stimulation
with Wnt3a. Using self-organizing maps, we identified clusters of
genes that exhibit similar expression dynamics and uncovered
previously unrecognized positive and negative feedback loops. We
also identified CTBP1 as an early response gene with a dynamic
expression profile that correlates with proliferation and migration.
We found that CtBP1 drives signaling by upregulating b-catenin
and serves as a novel marker of tumor progression in colorectal
adenocarcinomas.
Results and Discussion
Although the general topology of the Wnt network is reasonably
well understood, most investigations of Wnt signaling have focused
on one or a few components and have largely ignored signaling
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through this network, we used HEK 293 cells as an in vitro model
of normal Wnt signaling. We chose 293 cells because they have an
intact Wnt network and are responsive to canonical ligands,
including Wnt1 and Wnt3a [11,12,13]. Using quantitative real-
time PCR (qPCR), we found that most of the Wnt receptors,
including Fzd 1, 2, 3, 5, 6, 7, and 8, and LRP6, are expressed at
detectable levels (Supplementary Figure S1A and Supplementary
Table S1). Many of the Wnt ligands are also expressed, including
Wnt3, Wnt5a, and Wnt5b (Supplementary Figure S1B and
Supplementary Table S1). The expression of functional compo-
nents of the network and the fact that there are no mutations or
truncations in the genes encoding b-catenin or Adenomatous
polyposis coli (APC), make these cells an attractive model to study
normal Wnt signaling.
Wnt3a induces survival, proliferation, and migration in
HEK 293 cells
Most studies of Wnt signaling have used either Wnt3a-
conditioned media or overexpression of Wnt3a to activate cells
[13]. Both of these approaches activate canonical Wnt signaling,
but the results are convoluted with the response of the cells to
other growth factors present in the medium. To avoid this
problem, we used purified recombinant human Wnt3a to activate
signaling in serum-starved cells. To determine whether Wnt3a
could activate the transcriptional program mediated by b-catenin/
TCF, we used the well-characterized TOPglow and FOPglow
reporter constructs [14]. TOPglow features the gene for firefly
luciferase, under control of a TCF promoter; FOPglow features
the same reporter gene, but downstream of a mutated TCF-
binding site. As anticipated, luciferase activity was significantly
increased in response to Wnt3a stimulation in TOPglow-
transfected cells, but not in FOPglow-transfected cells (Supple-
mentary Figure S2A). In addition, we observed a time-dependent
increase in the overall levels of b-catenin by quantitative
immunoblotting, which is a hallmark of canonical signaling,
induced by Wnt3a [11,13] (Supplementary Figure S2B). The
increase in b-catenin was observed as early as five minutes after
adding Wnt3a to serum-starved cells, suggesting that b-catenin
levels are regulated post-transcriptionally (Supplementary Figure
S2B). Using confocal imaging, we observed increased b-catenin at
the membrane and in the cytosol upon Wnt3a stimulation, as
previously reported [15,16] (Supplementary Figure S2C).
The Wnt proteins are growth factors that have been shown to
play critical roles in proliferation and migration [1,17]. We found
that Wnt3a promotes proliferation of serum-starved HEK 293
cells relative to unstimulated cells (Supplementary Figure S3A),
consistent with previous studies [18,19]. We also found that Wnt3a
promotes cell survival, as serum-starvation-induced apoptosis was
inhibited in Wnt3a-treated cells relative to untreated cells
(Supplementary Figure S3B). Finally, using a Boyden chamber
assay, we found that Wnt3a promotes cell migration (Supplemen-
tary Figure S3C). Together, these experiments establish HEK 293
cells as a suitable system to study Wnt3a-mediated signaling in the
absence of the activating mutations found in most colorectal
cancer cell lines.
Monitoring the dynamics of gene expression reveals
positive and negative feedback loops
To obtain a global view of gene regulation in the Wnt signaling
network, we measured changes in the expression of 84 Wnt-related
genes in Wnt3a-stimulated HEK 293 cells at six different time
points over a 24-hour period using qPCR (Figure 1A and
Supplementary Tables S2 and S3). Previous studies of the
transcriptional response to Wnt ligands have focused on early
(4 hour) and late (24 hour) treatments [15,20]. Consistent with
these studies, we observed Wnt3a-dependent increases in the
transcript levels of canonical Wnt signaling genes at 3 and 6 hours,
including CTNNB1 (b-catenin) and DVL1 (Dishevelled-1), as well
as increases in canonical Wnt response genes at 24 hours,
including MYC and JUN.
Simple inspection of our data, however, revealed a rich diversity
in the time-dependent expression profiles (Figure 1A). To capture
and classify the various response patterns, we used self-organizing
maps. A self-organizing map is a type of artificial neural network
that uses unsupervised learning to group similar vector data
together. When we subjected our dynamic expression data to this
analysis, we observed six distinct profiles (Figure 1B). Interestingly,
most canonical Wnt response genes, including MYC and JUN, fell
into group IV, which was characterized by a monotonic increase
in mRNA levels over the entire 24-hour period, increasing rapidly
in the first three hours and then leveling off. In contrast, the genes
encoding negative regulators of Wnt signaling, such as secreted
Fzd-related protein 4 (sFRP-4), Dickkopf-1 (DKK-1), Idax, and
APC, fell into groups III and VI, which were both characterized
by downregulation of mRNA levels in the first three hours,
followed by subsequent increases. Thus the self-organizing maps
highlighted an early positive feedback loop in which negative
regulators of Wnt signaling are downregulated. Interestingly, both
sFRP-4 and DKK-1 have been shown to play important roles in
embryogenesis and oncogenesis [21]. Epigenetic silencing of
SFRP4 is frequently observed in colon cancer and usually occurs
early in cancer progression [22,23]. Additionally, it has been
shown that restoring expression of SFRP4 and DKK-1 in colorectal
cancer cells attenuates Wnt signaling, even in the presence of
activating mutations in CTNNB1 (b-catenin) and APC [23,24].
To obtain a biologically interpretable picture of gene regulation,
we mapped significant (greater than two-fold) changes in mRNA
levels onto a graphical depiction of the canonical Wnt signaling
network (Figure 2, A–C). Proteins whose genes were upregulated
are colored green, while those that were downregulated are
colored red. For clarity, only three time-points are shown in
Figure 2; all six time-points are provided in Supplementary Figure
S4. Using the terminology of Lauffenburger and coworkers [25],
the Wnt network can be viewed as comprising three informational
layers: the ‘cue’ (extracellular ligands that activate the network),
the ‘signal’ (intracellular proteins that transduce the message), and
the ‘response’ (transcriptional program that effects a phenotype).
Using this conceptual framework, we found that the Wnt3a-
induced transcriptional program is characterized by two distinct
phases: an early phase (0–3 hours) and a late phase (3–24 hours).
In the early phase, antagonists of the cue and signal are
downregulated (Figure 2, D–E). This is accompanied by a sharp
increase in the expression of signal and response genes. In the late
phase, antagonists of the cue, the signal, and the response are
upregulated and the transcription of response genes levels off or
even diminishes (Figure 2, D and F). Thus the early phase of Wnt
signaling is characterized by a transient positive feedback loop that
promotes the expression of signal and response genes, whereas the
late phase is characterized by a negative feedback loop that
attenuates signaling.
Using quantitative Western blotting, we also examined time-
dependent changes in the abundance of eight Wnt signaling
proteins upon stimulation of HEK 293 cells with Wnt3a.
Consistent with our transcriptional data and with previous studies
[16], we observed a Wnt3a-induced increase in the levels of b-
catenin, Naked1, Myc, CtBP1, CK1 and Dvl3 (Supplementary
Wnt Signaling: Systemwide Study
PLoS ONE | www.plosone.org 2 April 2010 | Volume 5 | Issue 4 | e10024Figure 1. Monitoring the dynamics of Wnt3a-induced gene expression in HEK 293 cells reveals distinct time-dependent expression
profiles. A. Heat map showing changes in the transcript levels of genes in the Wnt signaling network. HEK 293 cells were serum-starved for 24 hours
and stimulated for different lengths of time with 200 ng/mL Wnt3a. Transcript levels were measured by qPCR and normalized to the average of five
housekeeping genes. Changes are relative to serum-starved cells (0 h of stimulation). B. Genes with similar dynamic expression profiles were grouped
together using self-organizing maps. Most canonical Wnt response genes fell into group IV, whereas negative regulators of Wnt signaling fell into
groups III and VI.
doi:10.1371/journal.pone.0010024.g001
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behind the observed changes in transcript levels. Consistent with
our mRNA data, we also observed decreases in the abundances of
negative regulators of Wnt signaling, such as sFRP4 and DKK-1,
during the early phase of Wnt3a stimulation, and increases in their
abundances during the later phase (Supplementary Figure S5).
Mechanistically, sFRPs function as soluble antagonists of Wnt
signaling by binding directly to Wnt proteins and preventing their
interactions with Frizzled receptors[26,27]. Similarly, DKK-1
is a secreted antagonist of Wnt signaling that binds directly to
and inhibits the Wnt co-receptor LRP6 [28]. The downregulation
of these negative regulators, along with the upregulation of
positive regulators such as b-catenin, Myc, and CtBP1, combined
to augment Wnt signaling in the first three hours and
hence provide positive feedback. These same negative regulators
are downregulated at later time points, thereby attenuating
signaling.
c-Myc and CtBP1 are overexpressed in colorectal
adenocarcinomas
Havingidentified these novel phases of transcriptional regulation,
we asked if our dynamic expression profiles could be used to identify
genes that drive cellular proliferation and migration. We argued
that genes with time-dependent profiles that most closely correlated
with our quantitative measurements of proliferation and migration
(Supplementary Figure S3, A and C) are most likely to act in a
causal fashion. As correlation is not same as causation, however,
further experiments are required to establish causation in each
case. Using linear regression, we identified five genes with profiles
that correlated significantly (P,0.05) with either proliferation,
Figure 2. A knowledge-based view of the dynamics of gene expression reveals an early positive feedback loop, followed by a
subsequent negative feedback loop. A. Simplified schematic of the canonical Wnt signaling network. Only proteins whose transcript levels
changed by more than two-fold for at least one time point during the 24-hour time-course are shown. Cue and signal antagonists are outlined in
orange; response antagonists are outlined in purple; transcriptional response genes are colored blue. B, C. Simplified schematics of the Wnt signaling
network, highlighting proteins whose genes were upregulated (green) or downregulated (red) by more than two-fold after (B) 1 hour or (C) 12 hours
of stimulation with 200 ng/mL Wnt3a. Schematics showing changes at all six time-points are provided in Figure S4. D. Plot of changes in the
transcript levels of the proteins highlighted in panel (A). Cue and signal antagonists and shown in orange; response antagonists are shown in purple;
transcriptional response genes are shown in blue. (E, F) The transcriptional response to Wnt3a stimulation is characterized by two distinct phases: an
early phase (1–3 hours) and a late phase (3–24 hours). E. In the early phase, genes encoding cue and signal antagonists are downregulated, driving
the upregulation of signal and response genes. F. In the late phase, genes encoding cue, signal, and response antagonists are upregulated,
attenuating the expression of transcriptional response genes.
doi:10.1371/journal.pone.0010024.g002
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kinase 1a1), CTBP1 (C-terminal binding protein 1), and T
(Brachyury) (Figure 3A). All five genes are transcriptional response
genes and are found in self-organizing map IV (Figure 1B). c-Myc
andc-Jun aretranscriptionfactors that arewellknown todrivecycle
progression and are prototypical targets of canonical Wnt signaling
[9]. In addition, several isoforms of casein kinase 1 (CK1) have been
shown to positively regulate Wnt signaling [29]. The roles of CtBP1
and Brachyury, however, are less well defined.
Since aberrant Wnt signaling is strongly tied to colorectal
cancer, we measured the transcript levels of all five genes in 48
tissue samples obtained from patients with histopathologically
confirmed colon cancer (stage I, n=6; stage II, n=18; stage III,
n=14; stage IV, n=5), as well as in normal colon samples (n=5).
We found that MYC, JUN, and CTBP1 were significantly
overexpressed in all four stages of colorectal cancer compared
with normal tissue (P,0.05) (Figure 3, B and C, and Supplemen-
tary Figure S6A). In contrast, CSNK1A1 and T were not
Figure 3. Correlations between dynamic expression profiles and cellular phenotypes identify response genes that are significantly
overexpressed in colorectal carcinomas. A. Correlations were calculated between time-dependent expression profiles and either proliferation
(blue) or migration (red). The dotted line indicates a P-value of 0.05 (* P,0.05). B, C. Transcript levels of CtBP1 and c-Myc in human colorectal
carcinomas. Left: the relative levels of CtBP1 or c-Myc mRNA in normal colon tissue and in colorectal cancers of different stages. Horizontal bars
indicate the mean of each group. Right: the relative levels of CtBP1 and c-Myc mRNA were significantly higher in colon cancer tissue relative to
normal mucosa (* P,0.05; Kruskal-Wallis test). Error bars indicate the standard deviation. Data for Casein kinase 1a1, c-Jun, and Brachyury are
provided in Figure S6.
doi:10.1371/journal.pone.0010024.g003
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Consistent with these observations, we observed substantially
higher levels of c-Myc, CtBP1, and b-catenin in colon cancer cell
lines with constitutively active Wnt signaling than in CCD-18Co, a
normal colon fibroblast cell line [30] (Figure 4, A and B). In
addition, the levels of c-Myc and CtBP1 roughly tracked with the
tumorigenicity of the cell lines.
CtBP1 can act as both a transcriptional co-repressor and a
transcriptional activator [31,32,33,34,35]. It has been shown to
promote epithelial-mesenchymal transition (EMT) and to function
as an antagonist of apoptosis [36]. To further investigate the roles
of CtBP1 and c-Myc in driving Wnt signaling, we knocked down
their transcript levels by RNAi and measured the mRNA levels of
b-catenin, CtBP1, and c-Myc after 12 hours of stimulation with
Wnt3a. It has previously been suggested that c-Myc can promote
Wnt signaling by upregulating b-catenin. Consistent with this
notion, we found that b-catenin mRNA levels were significantly
decreased when c-Myc was knocked down (P,0.05) (Figure 4C).
Interestingly, the same result was observed when we knocked
down CtBP1, indicating that it also promotes Wnt signaling
through a positive feedback loop (Figures 4C and 4D). We also
found that knocking down the levels of c-Myc led to a significant
reduction in the levels of CtBP1 mRNA (P,0.05). As the Wnt3a-
dependent upregulation of CTBP1 precedes the upregulation of
MYC (Figure 2B and Supplementary Table S3), we conclude that
c-Myc promotes the expression of CTBP1 indirectly by upregulat-
ing b-catenin (Figure 4D). Knocking down the levels of CtBP1 did
not significantly affect c-Myc transcript levels. Previous studies
have shown, however, that in the absence of Wnt stimulation,
CtBP1 interacts with TCF-4 to represses the expression of MYC
[37]. Thus, we submit that knocking down CtBP1 has counter-
acting effects: it leads to decreased Wnt-independent repression of
MYC expression as well as decreased Wnt-dependent upregulation
of b-catenin. Overall, we conclude that c-Myc and CtBP1 are
largely independent response genes that promote Wnt signaling by
upregulating b-catenin.
To further investigate the role of CtBP1 in colorectal cancer, we
used tissue microarrays to assess the levels of the CtBP1 protein in
normal mucosa, as well as in adenocarcinoma tissue obtained from
75 patients with colorectal cancer (Figure 4, E and F). As
representative examples, Figure 4F shows CtBP1 staining in stage
II and stage IV cancers, along with normal tissue obtained from
the same patient. Overall, we evaluated 150 tumor cores for
CtBP1 staining and found that more than half of them exhibited
higher immunoreactivity scores in the tumor samples than in the
patient-matched normal tissue (Figure 4E). These data are
consistent with our in vitro observation that CtBP1 drives Wnt
signaling and identifies CtBP1 as a potential marker for colon
cancer progression. Our data are also consistent with a recent
study in zebrafish embryos that showed that loss of APC and
accumulation of CtBP1 represent early steps in cancer progression
(formation of adenomas), whereas nuclear localization of b-catenin
represents a later stage (carcinogenesis) [38]. Our time-dependent
expression profile highlights upregulation of CtBP1 as an early
event following activation of Wnt signaling and our subsequent
analysis of human colorectal tumors showed that CtBP1 is
overexpressed in early, as well as late-stage, cancers.
In summary, our system-wide and quantitative characterization
of transcriptional regulation uncovered previously unrecognized
positive and negative feedback loops that reveal how this network
is initially activated and subsequently attenuated. Further, these
time-dependent analyses highlighted CtBP1, a nuclear protein that
falls outside the canonical Wnt pathway and is overexpressed in all
four stages of colorectal adenocarcinoma. Identifying noncanoni-
cal components of the Wnt network that drive tumorigenesis may
provide novel strategies for developing effective therapeutics in a
network that, to date, has largely eluded pharmaceutical discovery.
Materials and Methods
Ethics Statement
N/A. An ethics statement is not required for this work. An
informed consent from participants involved is also not applicable
for this work.
Cell lines and reagents
HEK Flp-In-293 cells were obtained from Invitrogen (Carlsbad,
CA) and maintained in Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS),
2 mM glutamine, 100 IU/mL penicillin, and 100 mg/mL strep-
tomycin. Colon cancer cell lines (CCD-18co, Caco-2, DLD-1,
HT-29, HCT-116, and SW480) were obtained from American
Type Culture Collection (ATCC, Rockville, MD) and maintained
in DMEM supplemented with 10% FBS. Signal Silence c-Myc
siRNA was from Cell Signaling Technology (Danvers, MA) and
CtBP1 siRNA was from Santa Cruz Biotechnology (Santa Cruz,
CA). They were both introduced into cells using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instructions.
Recombinant human Wnt3a was from R&D Systems (Minnea-
polis, MN). Primary antibodies were obtained from the following
sources: rabbit anti-b-catenin (Cell Signaling Technology; cat.
#9562); rabbit anti-c-Myc (Cell Signaling Technology; cat.
#9402); rabbit anti-Naked1 (Cell Signaling Technology; cat.
#2262); rabbit anti-CK1 (Cell Signaling Technology; cat. #2655);
rabbit anti-Dvl3 (Cell Signaling Technology; cat. #3218); rabbit
anti-GSK3b (Cell Signaling Technology; cat. #9315); rabbit anti-
sFrp4 (Upstate Biotechnology Inc., Lake Placid, NY); cat #09-
129); mouse anti-Dkk-1(Millipore; cat #MAB10132); mouse anti-
b-actin (Sigma-Aldrich, Inc., St. Louis, MO; cat. #A1978); and
mouse anti-CtBP1 (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA; cat. #SC-17805).
Protein isolation and quantitative Western blotting
HEK 293 cells were serum-starved for 24 h and stimulated with
Wnt3a (200 ng/mL) for the appropriate length of time. Cells were
rinsed in Phosphate Buffered Saline (PBS) and lysed in Lysis Buffer
(20 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100 (v/v), 2 mM
EDTA, pH 7.8 supplemented with 1 mM sodium orthovanadate,
1 mM phenylmethylsulfonyl fluoride (PMSF), 10 mg/mL aprotinin,
and 10 mg/mL leupeptin). Protein concentrations were determined
using the BCA protein assay (Pierce, Rockford, IL) and immuno-
blotting experiments were performed using standard procedures.
For quantitative immunoblots, primary antibodies were detected
with IRDye 680-labeled goat-anti-rabbit IgG or IRDye 800-labeled
goat-anti-mouse IgG (LI-COR Biosciences, Lincoln, NE) at
1:10,000 dilution. Bands were visualized and quantified using an
Odyssey Infrared Imaging System (LI-COR Biosciences).
RNA extraction and quantitative real-time PCR
HEK 293 cells were serum-starved for 24 h and stimulated with
Wnt3a (200 ng/mL) for the appropriate length of time. Total
cellular RNA was isolated using an RNeasy Mini Kit (QIAGEN,
Santa Clara, CA). mRNA levels for the 84 Wnt-related genes were
determined using the RT
2 profiler
TM qPCR array (SA Biosciences
Corporation, Frederick, MD). Briefly, 1 mg of total RNA was
reverse transcribed into first strand cDNA using an RT
2 First
Strand Kit (SA Biosciences). The resulting cDNA was subjected to
qPCR using human gene-specific primers for 96 different genes,
Wnt Signaling: Systemwide Study
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(B2M, HPRT1, RPL13A, GAPDH, and ACTB). The qPCR reaction
was performed with an initial denaturation step of 10 min at 95uC,
followed by 15 s at 95uC and 60 s at 60uC for 40 cycles using an
Mx3000P
TM QPCR system (Stratagene, La Jolla, CA).
The mRNA levels of each gene were normalized relative to the
mean levels of the five housekeeping genes and compared with the
data obtained from unstimulated, serum-starved cells using the
2
2DDCt method. According to this method, the normalized level of
a mRNA, X, is determined using equation 1:
X~2{Ct GOI ðÞ
.
2{Ct CTL ðÞ ð1Þ
where Ct is the threshold cycle (the number of the cycle at which an
increase in reporter fluorescence above a baseline signal is detected),
GOI refers to the gene of interest, and CTL refers to a control
housekeeping gene. This method assumes that Ct is inversely
proportional to the initial concentration of mRNA and that the
amount of product doubles with every cycle. To determine the fold-
change in gene expression induced by stimulation with Wnt3a, the
normalized expressionof eachgene intheWnt3a-stimulated sample
was divided by the normalized expression of the same gene in the
unstimulated sample. The qPCR data presented are mean of three
biological replicates. Only gene whose mean transcript levels
changedbymorethantwo-foldforatleastonetimepointduringthe
24-hour time-course were considered significant. A self-organizing
map was generated with the Spotfire program to cluster genes with
self-similar expression profiles.
TOPglow/FOPglow reporter assay
For dual luciferase reporter assays, HEK 293 cells were co-
transfected with either TOPglow or FOPglow (Millipore, Billerica,
MA) and the pRL-TK control vector (Promega, Madison, WI).
After 48 h, cells were stimulated with 200 ng/mL Wnt3a for 24 h
and luciferase activity was measured using a dual luciferase
reporter kit (Promega).
Cell proliferation assay
Cell proliferation was measured using a BrdU proliferation
assay kit (Calbiochem, San Diego, CA). Briefly, cells were seeded
onto 96-well plates, serum-starved for 24 h, and incubated with
BrdU for 24 h. During the 24-h incubation, 200 ng/mL Wnt3a
was added at different times. At the end of the time course, cells
were fixed and analyzed for BrdU incorporation. Measurements
were performed in triplicate and normalized to untreated cells.
Cell migration assay
Cell migration was assessed using a QCM
TM chemotaxis 96-
well cell migration assay kit (Chemicon, Temecula, CA). Briefly,
HEK 293 cells were suspended in DMEM and plated in the top
chamber. DMEM containing 200 ng/mL Wnt3a was added to the
bottom chamber for different lengths of time. Migratory cells in
the bottom chamber were dissociated from the membrane, lysed,
and quantified by adding CyQuant GR dye. Measurements were
performed in triplicate and normalized to untreated cells.
Confocal microscopy
HEK 293 cells were cultured on Lab-Tek II chamber glass
slides (Nalge Nunc, Naperville, IL), serum-starved for 24 h, and
treated with 200 ng/mL Wnt3a for different lengths of time. Cells
were then fixed in 4% paraformaldehyde for 40 min at room
temperature, washed in PBS, permeabilized with 0.15% Triton X-
100, and blocked for 30 min with PBS containing 3% bovine
serum albumin (BSA). Cells were immunostained with a rabbit
anti-b-catenin antibody, following by an Alexa Fluor 488-labeled
goat-anti-rabbit antibody (Molecular Probes, Eugene, OR). The
nuclei were counterstained with Hoescht 33342 (Sigma-Aldrich,
St. Louis, MO). Fluorescent micrographs were obtained using a
Zeiss LSM510 META confocal microscope (Carl Zeiss, Jena,
Germany). Individual channels were overlaid using Image J
software, and localization was determined using the Image J
RG2B co-localization plug-in.
Apoptosis assays
HEK 293 cells were serum-starved for 24 h, stimulated with
200 ng/mL Wnt3a, harvested, fixed in absolute ethanol, and
treated with RNaseA at 37uC overnight. The cells were then
incubated in 5 mg/mL of propidium iodide for 15 min at room
temperature and cell cycle analysis was performed using a BD
LSRII flow cytometer (BD Biosciences, San Jose, CA). Measure-
ments were performed in triplicate and statistical significance was
calculated by one-way ANOVA.
TissueScan oncology panel arrays
A collection of 48 cDNA samples derived from tumor biopsies
was obtained from OriGene Technologies Inc. (Rockville, MD).
The samples represented all four stages of colon carcinoma, as well
as normal tissue. Gene expression was assessed by qPCR as
described above. The cancer data were normalized relative to the
data collected from the normal tissue samples and analyzed using
the Kruskal-Wallis test at a significance level of 0.05.
Tissue microarrays and immunohistochemistry
Two tissue microarrays featuring colon cancer with matching
normal mucosa were purchased from Pantomics, Inc. (Richmond,
CA). The first array comprised 16 cases of colon cancer, each in
duplicate, with corresponding normal tissue from the same patient
as a control. The other array comprised tissue, in duplicate, from
75 individuals, representing both normal colon and different
Figure 4. CtBP1 and c-Myc upregulate b-catenin and are markers of tumor progression in colorectal carcinomas. A. Western blots reveal
progressively higher levels of b-catenin, c-Myc, and CtBP1 in colon cancer cell lines of increasing tumorigenicity (Caco-2,DLD-1,
HT-29,HCT116,SW480), relative to the normal colon cell line, CCD-18Co. B. Quantification of the Western blot data in panel A. All values were
normalized to b-actin levels. C. Roles of CtBP1 and c-Myc in regulating gene expression. HEK 293 cells were transiently transfected with control siRNA or
siRNAs targeting either CtBP1 or c-Myc. After 48 hours, the cells were serum-starved for 24 hours and stimulated with 200 ng/mL Wnt3a for 12 hours.
Transcript levels were measured by qPCR. Knocking down either CtBP1 or c-Myc resulted in decreased levels of b-catenin. Data are the mean of two
independent experiments and error bars indicate the standard error of the mean (* P,0.05; one-way ANOVA). D. Pathway diagram illustrating the roles
of CtBP1 and c-Myc in Wnt3a-mediated activation of canonical Wnt signaling. The levels of both CtBP1 and c-Myc are upregulated in response to Wnt3a
stimulation.IntheabsenceofWnt3a,CtBP1actsatranscriptionalrepressorandinhibitstheexpressionofMYC.InthepresenceofWnt3a,bothCtBP1and
c-Myc drive Wnt signaling by upregulating b-catenin. E. Distribution of CtBP1 immunoreactivity scores in normal mucosa and in colorectal
adenocarcinomas determined using tissue microarrays (n=75 cases; 150 tumor cores). The immunoreactivity of CtBP1 was classified using a four-grade
scale: 0, fewer than 10% positively stained cells; 1, between 10% and 25%; 2, between 25% and 50%; and 3, greater than 50%. F. Representative images
fromthetissuemicroarrays,showingpatient-matchednormalandcanceroustissuefromstageIIandstageIVcolorectalcarcinomas (106magnification).
doi:10.1371/journal.pone.0010024.g004
Wnt Signaling: Systemwide Study
PLoS ONE | www.plosone.org 8 April 2010 | Volume 5 | Issue 4 | e10024grades and stages of colon cancer. Immunohistochemistry was
performed as previously described [39]. For negative controls,
primary antibody was omitted. The percentage of positive cells
was assessed visually in each core and the intensity of CtBP1
staining was classified using a four-grade scale: 0 indicated that
fewer than 10% of the cells were positive; 1, between 10% and
25%; 2, between 25% and 50%; and 3, greater than 50%.
Supporting Information
Figure S1 Relative mRNA levels of (A) Wnt receptors and (B)
Wnt ligands in HEK 293 cells. Total RNA was isolated from
serum-starved HEK 293 cells and mRNA levels were determined
by qPCR using gene-specific primers. All data are the mean of two
independent experiments and error bars indicate the standard
error of the mean (SEM).
Found at: doi:10.1371/journal.pone.0010024.s001 (0.65 MB EPS)
Figure S2 Wnt3a stimulation activates canonical Wnt signaling
in HEK 293 cells. (A) Wnt3a stimulation activates transcription
from the TCF promoter. HEK 293 cells were transiently
transfected with pRL-TK reporters and either TOPglow or
FOPglow. After stimulating the cells with 200 ng/mL Wnt3a, a
dual-luciferase assay was performed. Wnt3a induced transcription
in the TOPglow-transfected cells, but not in the FOPglow-
transfected cells (negative control). Data are the mean of two
independent experiments and error bars indicate the standard
error of the mean (SEM). (B) Western blot showing that Wnt3a
induces increased levels of b-catenin. Serum-starved HEK 293
cells were stimulated with 200 ng/mL Wnt3a and whole cell
lysates were collected at the indicated times. Western blots were
probed with antibodies directed at b-catenin and b-actin (loading
control). The bar graph provides relative levels of b-catenin,
normalized to b-actin levels. The error bars indicate SEM of two
biological repeats. (C) Localization of b-catenin in HEK 293 cells.
Serum-starved HEK 293 cells were stimulated with 200 ng/mL
Wnt3a for the indicated times and fixed in 4% paraformaldehyde.
Cells were stained with Hoechst dye (DNA; blue) and with an anti-
b-catenin antibody (red).
Found at: doi:10.1371/journal.pone.0010024.s002 (1.91 MB EPS)
Figure S3 Wnt3a stimulation promotes proliferation, survival,
and migration in HEK 293 cells. (A) Wnt3a stimulation induced
proliferation of HEK 293 cells over a 24-hour period. HEK 293
cells were serum-starved for 24 hours and incubated with BrdU
for 24 hours. Wnt3a was added to the cells at the indicated times
before the end of the 24-hour BrdU treatment. Data are the mean
of three independent experiments and error bars indicate the
standard error of the mean (SEM). (B) Wnt3a inhibits serum-
starvation-induced apoptosis. HEK 293 cells were serum-starved
for 24 hours and treated with Wnt3a for the indicated times. Cell
were fixed and stained with propidium iodide. The percentage of
apoptotic cells was measured by flow cytometry. Data are the
mean of two independent experiments and error bars indicate the
SEM. (C) Wnt3a induces migration of HEK 293 cells. HEK 293
cells were serum-starved for 24 hours and plated in the upper
chamber of a QCM
TM chemotaxis 96-well cell migration plate
while Wnt3a was added to the lower chamber. Migration of cells
from the upper to the lower chamber was measured using
CyQuant GR dye. Data are the mean of three independent
experiments and error bars indicate the SEM.
Found at: doi:10.1371/journal.pone.0010024.s003 (0.96 MB EPS)
Figure S4 A knowledge-based view of the dynamics of gene
expression in the Wnt signaling network. (A) Simplified schematic
of the canonical Wnt signaling network. Only proteins whose
transcript levels changed by more than two-fold are shown. Cue
and signal antagonists are outlined in orange; response antagonists
are outlined in purple; transcriptional response genes are colored
blue. (B–F) Simplified schematics of the Wnt network, highlighting
proteins whose genes were upregulated (green) or downregulated
(red) by more than two-fold after stimulation with 200 ng/mL
Wnt3a for different lengths of time.
Found at: doi:10.1371/journal.pone.0010024.s004 (3.72 MB EPS)
Figure S5 Changes in protein abundance upon stimulation of
HEK 293 cells with Wnt3a. (A) Simplified schematic of the
canonical Wnt signaling network. Proteins whose levels were
monitored by quantitative Western blotting are highlighted in
orange. (B) Dynamic profiles of eight Wnt signaling proteins
following stimulation with Wnt3a. Whole cell lysates were
analyzed by Western blotting and protein levels were normalized
to b-actin levels. Relative protein levels were calculated for each
protein by first subtracting the level observed in the untreated
sample and then dividing by the maximum oberved value. All data
are the mean of at least two independent experiments and error
bars indicate the standard error of the mean (SEM).
Found at: doi:10.1371/journal.pone.0010024.s005 (2.22 MB EPS)
Figure S6 Transcript levels of c-Jun, CK1a1, and Brachyury in
human colorectal carcinomas. Left: the relative levels of (A) c-Jun,
(B) CK1a1, and (C) Brachyury mRNA in normal colon tissue and
in colorectal cancers of different stages were measured by qPCR.
Horizontal bars indicate the mean of each group. Right: the
relative levels of c-Jun mRNA were significantly higher in colon
cancer tissue relative to normal mucosa (* P,0.05; Kruskal-Wallis
test). The relative leves of CK1a1 and Brachyury mRNA were not
significantly higher. Error bars indicate the standard deviation.
Found at: doi:10.1371/journal.pone.0010024.s006 (1.75 MB EPS)
Table S1 Expression levels of Wnt receptors and Wnt ligands in
HEK 293 cells. The Ct values are the means of at least two
biological replicates.
Found at: doi:10.1371/journal.pone.0010024.s007 (0.04 MB
DOC)
Table S2 Wnt signaling genes assessed by quantitative real-time
PCR.
Found at: doi:10.1371/journal.pone.0010024.s008 (0.09 MB
DOC)
Table S3 Relative changes in the expression levels of Wnt
signaling genes in response to stimulation with Wnt3a.
Found at: doi:10.1371/journal.pone.0010024.s009 (0.12 MB
DOC)
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